Market Highlights
Bone grafting is a surgical procedure used to operate severely complicated bone fractures. Bone grafts are implantable materials used during a medical process to aid in bone formation, bone healing, and osseous reconstruction. In contrast to autogenous or allogenous bone, a bone substitute can be described as a synthetic, inorganic, or biologically organic combination that can fill bone defects instead.
The global Bone Graft Substitute Market Share is expected to register a CAGR of 6.29% during the forecast period and hit USD 4,408.50 million by 2027.
The global bone graft substitute market is mainly driven by the rising incidents of road injuries and joint disorders, the development of biocompatible synthetic bone grafts, and increased demand for dental bone graft procedures. However, several factors such as the high costs of surgery and risks and complications arising from bone graft procedures are restraining the growth of the market.
Segment Analysis
The global bone graft substitute market has been divided based on product type and application.
Based on product type, the market has been segregated into allograft, bone graft, and substitute cell-based matrices.Allografts are further segmented into machine allografts and Demineralized Bone Matrix (DBM). Bone grafts are also further segmented into synthetic bone graft and bone morphogenic proteins.
Based on application, the bone graft substitute market has been divided intospinal fusion, joint reconstruction, long bone, dental, foot & ankle, and others.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1195
Regional Analysis:
The global bone graft substitute market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to dominate with the largest market share due to the high numberof orthopedic surgeries, adoption of bone graft substitutes, and the presence of prominent key players.Europe accounted for a substantial share in the global bone graft substitute market. Europe has evolved as a prominent market with the growing awareness about bone graft substitutes and surging healthcare expenses. The region has considerable growth potentials that would help in the expansion of the global market in the coming years.Asia-Pacific is projected to be the fastest-growing regionin the bone graft substitute market, mainly due to the presence of evolving economies, such as India, China, and South Korea, and the increasing potential patient population.The market in the Middle East & Africa is also growing dramatically due to the increasing number of research companies and subsidiaries involved in R&D, increasing initiatives taken by the Middle East countries to develop their healthcare infrastructure.Moreover, the growing awareness and demand from the general population for effective orthopedic treatments are likely to favor the market growth.
List of Key Companies Covered in this report:
- Medtronic Plc (Ireland)
- AlloSource (US)
- Zimmer Biomet Holdings Inc. (US)
- Stryker (US)
- Smith & Nephew (UK)
- Johnson & Johnson Services, Inc. (US)
- Baxter International Inc. (US)
- Integra Lifesciences Holdings Corporation (US)
- Orthofix Holdings Inc. (US)
- Geistlich Pharma AG (Switzerland)
- SeaSpine (US)
Key Findings of the Study:
- The global bone graft substitute market was valued at USD 2,890.2millionin 2020 and is projected to register a CAGR of6.29% during the assessment period.
- The Americas accounted for the largest share of the global market due to the growing awareness and demand for effective orthopedictreatmentsfrom the general.
- Based on product type, the allograftsegment accounted for the largest market share with a value of USD 1,446.8 million in 2020.
- Based on application, the spinal fusionsegment accounted for the largest market share with a value of USD 915.9million in 2020.
- Medtronic Plc (Ireland), AlloSource (US), Zimmer Biomet Holdings Inc. (US), and Stryker (US) are the key market players.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/bone-graft-substitutes-market-1195
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
Market Synopsis:Market Research Future (MRFR)’s latest study reveals that the global bone graft substitutes market is expected to expand at 6.52% CAGR during the forecast period 2017 to 2027.
Additionally, the rising awareness about the developments in bone graft substitutes coupled with rising healthcare expenditure is likely to augment the market size and revenue over the next couple of years.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/1195The painful procedure related to autografts have paved the way for developments in the bone graft substitutes market.
Hence, the demand for alternatives such as allografts, xenografts, and synthetic bone grafts has been on the rise.
are prognosticated to restrict the market expansion over the forecast period.Market Segmentation:By type, the global bone graft substitutes market is segmented into autograft, demineralized bone matrix, synthetic bone grafts, bone morphogenetic protein, and others.By application, the bone graft substitutes market has been segmented into spinal fusion, joint reconstruction, long bone, dental, foot & ankle, and others.Regional Insights:By region, the global bone graft substitutes market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa.
The growth is attributable to the technological advancements in health care, the presence of key players, etc.
The developed healthcare sector of the U.S. is poised to be one of the primary revenue generators in the regional bone graft substitutes market.Europe is the second largest market for bone graft substitutes.
